Bone Mineral Density in Long-Term Chinese Heart Transplant Recipients: A Cross-Sectional Study

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2141-2144

  Chou, N K ^a   Su, I C ^a   Kuo, H L ^a   Chen, Y H ^a   Yang, R S ^a   Wang, S S ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CREATININE; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BONE DENSITY; CARDIAC GRAFT REJECTION; CHINESE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOASSAY; LUMBAR SPINE; MALE; MINERAL METABOLISM; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL;

ADULT; AGED; BODY SIZE; BONE DENSITY; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDNISOLONE; TAIWAN; TIME FACTORS;

EID: 33846081033     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.044     Document Type: Article

References (12)

1. Carruthers S.G., Hoffman B.B., Melmon K.L., et al. Melmon and Morrelli's Clinical Pharmacology: basic principles in therapeutics. 4th ed. (2000), McGraw-Hill 470
2. Shane E., Rivas M., McMahon D.J., et al. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 82 (1997) 1497
3. Shane E., Rivas M.D., Silverberg S.J., et al. Osteoporosis after cardiac transplantation. Am J Med 94 (1993) 257
4. Shane E., Mancini D., Aaronson K., et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 103 (1997) 197
5. Rodino M.A., and Shane E. Osteoporosis after organ transplantation. Am J Med 104 (1998) 459
6. Braith R.W., Howard C.H., Fricker J., et al. Glucocorticoid-induced osteopenia in adolescent heart transplant recipients. J Heart Lung Transplant 19 (2000) 840
7. Höfle G., Holzmüller H., Gouya G., et al. Lower serum β-CrossLaps in male cardiac transplant recipients treated without prednisolone. Transpl Int 16 (2003) 523
8. Movsowitz C., Epstein S., Fallon M., et al. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 123 (1988) 2571
9. Bowman A.R., Dass D.A., Dissanayake I.R., et al. The role of testosterone cyclosporine-induced osteopenia. J Bone Miner Res 12 (1997) 607
10. Thiebaud D., Krieg M.A., Gillard-Berguer D., et al. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 26 (1996) 549
11. Durieux S., Mercadal L., Orcel P., et al. Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation 74 (2002) 496
12. Negri A.L., Perrone S., Gallo R., et al. Osteoporosis following heart transplantation. Transplant Proc 28 (1996) 3321